Raju Mohan

1.9k total citations
35 papers, 1.3k citations indexed

About

Raju Mohan is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Raju Mohan has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 14 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Raju Mohan's work include Chemical Synthesis and Analysis (7 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Synthetic Organic Chemistry Methods (5 papers). Raju Mohan is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Synthetic Organic Chemistry Methods (5 papers). Raju Mohan collaborates with scholars based in United States, India and Germany. Raju Mohan's co-authors include Barry B. Snider, Steven A. Kates, Michael M. Morrissey, Brad O. Buckman, Richard A. Heyman, Richard Martin, Brett B. Busch, William C. Stevens, Robert A. Horlick and Sihong Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Biochemistry.

In The Last Decade

Raju Mohan

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raju Mohan United States 19 647 579 219 204 107 35 1.3k
Hiroki Kakuta Japan 20 693 1.1× 365 0.6× 136 0.6× 270 1.3× 68 0.6× 84 1.3k
Curt D. Haffner United States 16 616 1.0× 244 0.4× 492 2.2× 126 0.6× 243 2.3× 22 1.2k
Bryan H. Norman United States 26 549 0.8× 667 1.2× 292 1.3× 166 0.8× 39 0.4× 49 1.4k
F. Javier Piedrafita United States 19 950 1.5× 205 0.4× 158 0.7× 258 1.3× 59 0.6× 42 1.5k
Hiroyuki Miyachi Japan 20 626 1.0× 225 0.4× 110 0.5× 101 0.5× 48 0.4× 38 902
Christopher J. O’Donnell United States 27 835 1.3× 799 1.4× 483 2.2× 75 0.4× 52 0.5× 54 2.1k
Xavier de Leval Belgium 25 415 0.6× 422 0.7× 143 0.7× 139 0.7× 66 0.6× 46 1.4k
Huiping Zhao United States 26 968 1.5× 277 0.5× 175 0.8× 163 0.8× 53 0.5× 58 1.6k
Kwang Rok Kim South Korea 17 462 0.7× 360 0.6× 157 0.7× 59 0.3× 79 0.7× 29 1.1k
Cynthia D. Sommers United States 17 566 0.9× 152 0.3× 177 0.8× 104 0.5× 88 0.8× 39 1.1k

Countries citing papers authored by Raju Mohan

Since Specialization
Citations

This map shows the geographic impact of Raju Mohan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raju Mohan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raju Mohan more than expected).

Fields of papers citing papers by Raju Mohan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raju Mohan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raju Mohan. The network helps show where Raju Mohan may publish in the future.

Co-authorship network of co-authors of Raju Mohan

This figure shows the co-authorship network connecting the top 25 collaborators of Raju Mohan. A scholar is included among the top collaborators of Raju Mohan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raju Mohan. Raju Mohan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basha, N. Jeelan & Raju Mohan. (2024). Insight on Heterocycles as p53‐MDM2 Protein‐Protein Interaction Inhibitors: Molecular Mechanism for p53 Activation. ChemistrySelect. 9(10). 3 indexed citations
2.
Basha, N. Jeelan, et al.. (2024). Synthesis, molecular docking, drug likeness, in silico toxicity and DFT studies of small molecules as p53-MDM2 interaction and COX-2 dual inhibitors. Journal of Molecular Structure. 1322. 140393–140393. 1 indexed citations
3.
Luo, Allison, Robert S. Lester, Robert M. Schwab, et al.. (2020). Tu1852 PHARMACOKINETICS AND PHARMACODYNAMICS OF OPL-002, A HIGHLY SELECTIVE S1P1R MODULATOR, IN HEALTHY ADULT VOLUNTEERS.. Gastroenterology. 158(6). S–1188. 3 indexed citations
4.
Islam, Imadul, Shendong Yuan, Wei Xu, et al.. (2018). Reversible, orally available ADP receptor (P2Y12) antagonists Part I: Hit to lead process. Bioorganic & Medicinal Chemistry Letters. 28(9). 1459–1463. 7 indexed citations
5.
Kick, Ellen K., Richard Martin, Yinong Xie, et al.. (2014). Liver X Receptor (LXR) partial agonists: Biaryl pyrazoles and imidazoles displaying a preference for LXRβ. Bioorganic & Medicinal Chemistry Letters. 25(2). 372–377. 33 indexed citations
6.
Kirchgessner, Todd G., Richard Martin, Paul G. Sleph, et al.. (2014). Pharmacological Characterization of a Novel Liver X Receptor Agonist with Partial LXRα Activity and a Favorable Window in Nonhuman Primates. Journal of Pharmacology and Experimental Therapeutics. 352(2). 305–314. 25 indexed citations
7.
Mohan, Raju, et al.. (2013). MICROFLUIDIC PLATFORM FOR RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING OF POLYMICROBIAL COMMUNITIES. 1353–1355. 1 indexed citations
8.
Martin, Richard, Tielin Wang, Paige E. Mahaney, et al.. (2009). Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR). Journal of Medicinal Chemistry. 52(4). 904–907. 141 indexed citations
9.
Islam, Imadul, Judi Bryant, Karen May, et al.. (2006). 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa). Bioorganic & Medicinal Chemistry Letters. 17(5). 1349–1354. 25 indexed citations
10.
Buckman, Brad O., Amy Liang, Dao Lentz, et al.. (2005). Solid-phase synthesis of naphthylamidines as factor VIIa/tissue factor inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(9). 2249–2252. 11 indexed citations
11.
Mohan, Raju & Richard A. Heyman. (2003). Orphan Nuclear Receptor Modulators. Current Topics in Medicinal Chemistry. 3(14). 1637–1647. 68 indexed citations
12.
Buckman, Brad O., et al.. (2002). Automated Parallel Solid-Phase Synthesis of Non-Peptide CCR1 Receptor Antagonists. Combinatorial Chemistry & High Throughput Screening. 5(3). 249–251. 1 indexed citations
13.
Ng, Howard P., Brad O. Buckman, Keith Eagen, et al.. (2002). Design, Synthesis, and Biological Activity of Novel Factor Xa Inhibitors: 4-Aryloxy Substituents of 2,6-Diphenoxypyridines††See ref. 1.. Bioorganic & Medicinal Chemistry. 10(3). 657–666. 6 indexed citations
14.
Whitlow, Marc, Brad O. Buckman, David D. Davey, et al.. (1999). Crystallographic analysis of potent and selective factor Xa inhibitors complexed to bovine trypsin. Acta Crystallographica Section D Biological Crystallography. 55(8). 1395–1404. 30 indexed citations
15.
Xu, Wei, Raju Mohan, & Michael M. Morrissey. (1998). Polymer supported bases in solution-phase synthesis. 2. A convenient method for N-alkylation reactions of weakly acidic heterocycles. Bioorganic & Medicinal Chemistry Letters. 8(9). 1089–1092. 17 indexed citations
16.
Buckman, Brad O., et al.. (1998). Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(16). 2235–2240. 47 indexed citations
17.
Mohan, Raju, Weiya Yun, Brad O. Buckman, et al.. (1998). Solid-phase synthesis of N-substituted amidinophenoxy pyridines as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(14). 1877–1882. 12 indexed citations
18.
Mohan, Raju, et al.. (1991). Synthesis and biological activity of angiotensin II analog containing a Val-His replacement, Val.psi.[CH(CONH2)HN]His. Journal of Medicinal Chemistry. 34(8). 2402–2410. 18 indexed citations
19.
Cade, Christina, et al.. (1990). Lack of biological activity of preproendothelin [110–130] in several endothelin assays. Life Sciences. 47(23). 2097–2103. 4 indexed citations
20.
Mohan, Raju, Steven A. Kates, Mark A. Dombroski, & Barry B. Snider. (1987). Manganese (III) based oxidative free-radical cyclizations. 3. Polycyclization reactions proceeding through secondary radicals.. Tetrahedron Letters. 28(8). 845–848. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroki Kakuta Breakdown of academic impact, for papers by Curt D. Haffner Breakdown of academic impact, for papers by Bryan H. Norman Breakdown of academic impact, for papers by F. Javier Piedrafita Breakdown of academic impact, for papers by Hiroyuki Miyachi Breakdown of academic impact, for papers by Christopher J. O’Donnell Breakdown of academic impact, for papers by Xavier de Leval Breakdown of academic impact, for papers by Huiping Zhao Breakdown of academic impact, for papers by Kwang Rok Kim Breakdown of academic impact, for papers by Cynthia D. Sommers
Rankless by CCL
2026